Linda M. Rubinstein - 03 Aug 2023 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADVM	Stock Option (Right to Buy)	Award	$0	+850,000		$0.000000	850,000	03 Aug 2023	Common Stock	850,000	$2.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Non-Statutory Stock Option to purchase 850,000 shares granted under the Issuer's 2014 Equity Incentive Plan (the "Plan"), 25% vesting 6 months from the Reporting Person's first day of employment with the Issuer, and 17,708.33 shares vesting monthly thereafter for the next 36 months, subject to the Reporting Person's continued service with the Issuer on each such vesting date.